• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斯帕克斯的山魈移植术。对查尔斯·H·斯帕克斯及其同事所进行的山魈移植术的七年随访。

The Sparks' mandril graft. A seven year follow-up of mandril grafts placed by Charles H. Sparks and his associates.

作者信息

Hallin R W, Sweetman W R

出版信息

Am J Surg. 1976 Aug;132(2):221-3. doi: 10.1016/0002-9610(76)90051-9.

DOI:10.1016/0002-9610(76)90051-9
PMID:133619
Abstract

A clinical follow-up study of the Sparks' mandril graft used for lower extremity revascularization between 1968 and 1973 is presented. Of seventy-three mandril grafts placed, sixty were used to revascularize lower extremities in fifty-four patients. Results show 100 per cent patency in the ilioiliac and ilio-femoral sites, 26 per cent patency in the femoropopliteal sites, and 0 per cent patency in the femorotibial and axillofemoral grafts. Complications include poor maturation of the graft, early thrombosis, postoperative hemorrhage, and aneurysm.

摘要

本文介绍了1968年至1973年间用于下肢血管重建的斯帕克斯狒狒移植的临床随访研究。在植入的73个狒狒移植中,有60个用于为54例患者的下肢进行血管重建。结果显示,髂髂和髂股部位的通畅率为100%,股腘部位的通畅率为26%,股胫和腋股移植的通畅率为0%。并发症包括移植成熟不良、早期血栓形成、术后出血和动脉瘤。

相似文献

1
The Sparks' mandril graft. A seven year follow-up of mandril grafts placed by Charles H. Sparks and his associates.斯帕克斯的山魈移植术。对查尔斯·H·斯帕克斯及其同事所进行的山魈移植术的七年随访。
Am J Surg. 1976 Aug;132(2):221-3. doi: 10.1016/0002-9610(76)90051-9.
2
Complications with the mandril-grown (Sparks) dacron arterial graft.曼德里尔生长(斯帕克斯)涤纶动脉移植物的并发症。
Am Surg. 1975 Sep;41(9):550-4.
3
[Remote results and critical review of the use of the Sparks-Mandril prosthesis].[斯帕克斯-曼德里尔假体使用的远程结果及批判性综述]
Minerva Chir. 1980 Oct 15;35(19):1461-70.
4
Sparks mandril, velour Dacron and autogenous saphenous vein grafts in femoropopliteal bypass.股腘动脉搭桥术中的斯帕克斯卷须、天鹅绒涤纶和自体大隐静脉移植物
Br J Surg. 1979 Jul;66(7):514-7. doi: 10.1002/bjs.1800660720.
5
[Sparks-mandril prosthesis and a new alternative in obstructions of the femoro-popliteal axis].[斯帕克斯-曼德里尔假体与股腘轴阻塞的一种新选择]
Minerva Chir. 1976 May 15;31(9):473-87.
6
Innovative applications of extra-anatomic reconstruction.
Surg Clin North Am. 1974 Feb;54(1):123-35. doi: 10.1016/s0039-6109(16)40239-2.
7
Twelve year experience with axillofemoral and femorofemoral bypass operations.腋股和股股旁路手术的十二年经验。
Surg Gynecol Obstet. 1978 Dec;147(6):881-7.
8
Treatment of aortoiliac disease by axillofemoral artery bypass.
Can J Surg. 1979 Jan;22(1):19-21.
9
The Sparks mandril in femoropopliteal bypass.股腘动脉搭桥术中的斯帕克斯 mandril(此处 mandril 可能有误,暂按原样翻译)
Br Med J. 1977 Nov 5;2(6096):1190-1. doi: 10.1136/bmj.2.6096.1190-a.
10
[Sparks grafts as arterial substitutes in the femoro-popliteal region with a postoperative follow-up of up to 54 months].[斯帕克斯移植物作为股腘区域的动脉替代物,术后随访长达54个月]
Helv Chir Acta. 1981 Apr;48(1-2):243-50.

引用本文的文献

1
Artificial blood vessels-clinical development of TEVG.人工血管——组织工程血管移植物的临床进展
J Artif Organs. 2025 May 26. doi: 10.1007/s10047-025-01508-9.
2
In vivo efficacy of a polymer layered decellularized matrix composite as a cell honing cardiovascular tissue substitute.聚合物分层脱细胞基质复合材料作为细胞优化心血管组织替代物的体内疗效
Mater Today Bio. 2022 Oct 23;17:100451. doi: 10.1016/j.mtbio.2022.100451. eCollection 2022 Dec 15.
3
Bioengineering Human Tissues and the Future of Vascular Replacement.生物工程化人体组织与血管替代的未来
Circ Res. 2022 Jun 24;131(1):109-126. doi: 10.1161/CIRCRESAHA.121.319984. Epub 2022 Jun 23.
4
Mechanically reinforced biotubes for arterial replacement and arteriovenous grafting inspired by architectural engineering.受建筑工程启发的用于动脉置换和动静脉移植的机械增强生物管。
Sci Adv. 2022 Mar 18;8(11):eabl3888. doi: 10.1126/sciadv.abl3888. Epub 2022 Mar 16.
5
Can a Peritoneal Conduit Become an Artery?腹膜导管能变成动脉吗?
EJVES Vasc Forum. 2020 Oct 13;49:23-29. doi: 10.1016/j.ejvsvf.2020.10.001. eCollection 2020.
6
Cellular remodeling of fibrotic conduit as vascular graft.作为血管移植物的纤维化导管的细胞重塑。
Biomaterials. 2021 Jan;268:120565. doi: 10.1016/j.biomaterials.2020.120565. Epub 2020 Dec 1.
7
Combination of inductive effect of lipopolysaccharide and in situ mechanical conditioning for forming an autologous vascular graft in vivo.体内形成自体血管移植物的内毒素感应作用与原位机械调节相结合。
Sci Rep. 2019 Jul 23;9(1):10616. doi: 10.1038/s41598-019-47054-2.
8
Quickening: Translational design of resorbable synthetic vascular grafts.快速发展:可吸收合成血管移植物的转化设计。
Biomaterials. 2018 Aug;173:71-86. doi: 10.1016/j.biomaterials.2018.05.006. Epub 2018 May 5.
9
A short discourse on vascular tissue engineering.关于血管组织工程的简短论述。
NPJ Regen Med. 2017;2. doi: 10.1038/s41536-017-0011-6. Epub 2017 Mar 27.
10
Utilizing the Foreign Body Response to Grow Tissue Engineered Blood Vessels in Vivo.利用异物反应在体内生长组织工程血管
J Cardiovasc Transl Res. 2017 Apr;10(2):167-179. doi: 10.1007/s12265-017-9731-7. Epub 2017 Feb 15.